Jason Raleigh Nunn
CIK 1444319 · last filed 2025-10-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$23.27M
Companies
6
Total Filings
41
Lifetime Open-Market Net
$16.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZBIO | Director | 1,173,395 | $19.80 | $23.23M | $16.20M | 3 | 2025-10-14 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 0 | $8.16 | $0 | $0 | 10 | 2025-06-27 |
| TRVN | Director | 4,271 | $0.01 | $47 | $0 | 11 | 2024-06-14 |
| DERM | Director | 6,000 | $6.34 | $38.0K | $0 | 7 | 2019-06-14 |
| TriVascular Technologies, Inc. (TRIV) Delisted | Director | — | — | — | $0 | 1 | 2015-05-27 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | Director | — | — | — | $0 | 1 | 2013-05-01 |
Recent Filings · Page 2 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-13 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | TRVN | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-15 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-02 | TRVN | Grant (A) | — | $0 | EDGAR |
| 2020-06-19 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-15 | TRVN | Grant (A) | — | $0 | EDGAR |
| 2020-02-24 | — | Disp (D) | −6,000 | -$112.5K | |
| 2019-10-15 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-14 | DERM | Exer (M) | +3,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.